Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Charles Fruchart

Showing results (21-30 of 167) with videos related to

Pageof 17
Sort By:
Drug News & Perspectives|April 22, 2006
Retinoic acid receptor-related orphan receptor alpha as a therapeutic target in the treatment of dyslipidemia and atherosclerosisHeidelinde Jakel, Jamila Fruchart-Najib, Jean-Charles Fruchart
Current Atherosclerosis Reports|August 18, 2005
Pleiotropic effects of fibratesGiulia Chinetti-Gbaguidi, Jean Charles Fruchart, Bart Staels
Current Opinion in Pharmacology|March 23, 2005
Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapyGiulia Chinetti-Gbaguidi, Jean-Charles Fruchart, Bart Staels
Circulation Research|May 15, 2004
Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cellsNikolaus Marx, Hélène Duez, Jean-Charles Fruchart, et al.
Journal De La Societe De Biologie|July 24, 2002
[Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control]Virginie Bocher, Giulia Chinetti, Jean-Charles Fruchart, et al.
Journal of the American College of Nutrition|June 14, 2003
Postprandial leptin response to carbohydrate and fat meals in obese womenMonique Romon, Pascal Lebel, Jean-Charles Fruchart, et al.
Trends in Endocrinology and Metabolism: TEM|September 8, 2004
Genomic and non-genomic interactions of PPARalpha with xenobiotic-metabolizing enzymesOlivier Barbier, Coralie Fontaine, Jean-Charles Fruchart, et al.
The Journal of Clinical Investigation|March 3, 2006
Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasisPhilippe Lefebvre, Giulia Chinetti, Jean-Charles Fruchart, et al.
Expert Opinion on Emerging Drugs|August 31, 2006
Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosisBenoit Pourcet, Jean-Charles Fruchart, Bart Staels, et al.
Current Atherosclerosis Reports|July 17, 2020
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?Jean-Charles Fruchart, Michel P Hermans, Jamila Fruchart-Najib
Pageof 17

Showing results (21-30 of 167) with videos related to

Sort By:
Pageof 17
Drug News & Perspectives|April 22, 2006
Retinoic acid receptor-related orphan receptor alpha as a therapeutic target in the treatment of dyslipidemia and atherosclerosisHeidelinde Jakel, Jamila Fruchart-Najib, Jean-Charles Fruchart
Current Atherosclerosis Reports|August 18, 2005
Pleiotropic effects of fibratesGiulia Chinetti-Gbaguidi, Jean Charles Fruchart, Bart Staels
Current Opinion in Pharmacology|March 23, 2005
Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapyGiulia Chinetti-Gbaguidi, Jean-Charles Fruchart, Bart Staels
Circulation Research|May 15, 2004
Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cellsNikolaus Marx, Hélène Duez, Jean-Charles Fruchart, et al.
Journal De La Societe De Biologie|July 24, 2002
[Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control]Virginie Bocher, Giulia Chinetti, Jean-Charles Fruchart, et al.
Journal of the American College of Nutrition|June 14, 2003
Postprandial leptin response to carbohydrate and fat meals in obese womenMonique Romon, Pascal Lebel, Jean-Charles Fruchart, et al.
Trends in Endocrinology and Metabolism: TEM|September 8, 2004
Genomic and non-genomic interactions of PPARalpha with xenobiotic-metabolizing enzymesOlivier Barbier, Coralie Fontaine, Jean-Charles Fruchart, et al.
The Journal of Clinical Investigation|March 3, 2006
Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasisPhilippe Lefebvre, Giulia Chinetti, Jean-Charles Fruchart, et al.
Expert Opinion on Emerging Drugs|August 31, 2006
Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosisBenoit Pourcet, Jean-Charles Fruchart, Bart Staels, et al.
Current Atherosclerosis Reports|July 17, 2020
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?Jean-Charles Fruchart, Michel P Hermans, Jamila Fruchart-Najib
Pageof 17